Moores UCSD Cancer Centre studying novel leukaemia vaccine for high-risk patients
Tuesday, November 4, 2008 - 11:14
in Health & Medicine
Researchers at the Moores Cancer Centre at the University of California, San Diego (UCSD) are conducting clinical trials of a novel therapy aimed at revving up the immune system to combat a particularly difficult-to-treat form of leukaemia...
Read the whole article on Science Centric
More from Science Centric
Related
- Moores UCSD Cancer Center studying novel leukemia vaccine for high-risk patientsTue, 4 Nov 2008, 11:15:51 EST
- Novel Lung Cancer Vaccine Trial Launched at Moores UCSD Cancer CenterWed, 8 Oct 2008, 3:44:36 EDT
- UCSD researchers identify potential new drug target for chronic leukemiaMon, 24 Nov 2008, 18:01:16 EST
- Moores UCSD Cancer Center study links vitamin D, type 1 diabetesThu, 5 Jun 2008, 7:07:54 EDT
- New biomarker may predict leukemia aggressivenessSun, 19 Apr 2009, 15:43:11 EDT